Jong Joseph Kim

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Plymouth Meeting, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jong Joseph Kim
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jong Joseph Kim

Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Restricted Stock Unit
Shares / value
139,386
Estimated value
$1,137,390
Report date
11 Mar 2022
Price
$8.16
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
1,422,627
Estimated value
$796,671
Report date
11 Mar 2022
Price
$0.5600
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
816,527
Estimated value
$457,255
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Family Limited Partnership
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
33,775
Estimated value
$18,914
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Son: JK1
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
33,563
Estimated value
$18,795
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Daughter: EK
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
33,533
Estimated value
$18,778
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Son: JK2
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
5,975
Estimated value
$3,346
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Spouse
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock Option
Shares / value
627,700
Estimated value
Report date
26 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jong Joseph Kim

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .